Brief: AngioDynamics Enrolls First Patient In AMBITION BTK Trial Advancing Treatment For Critical Limb Ischemia
28/07/2025 13:44
July 28 (Reuters) - AngioDynamics Inc ANGO.O: ANGIODYNAMICS ENROLLS FIRST PATIENT IN AMBITION BTK TRIAL ADVANCING TREATMENT FOR CRITICAL LIMB ISCHEMIA Source text: ID:nBw3Gnc9da Further company coverage: ANGO.O (Reporting by Anshi Sancheti) ((Anshi.Sancheti@thomsonreuters.com;))
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary